Artelo Biosciences (ARTL) Free Cash Flow Growth (3y) (2017 - 2025)
Artelo Biosciences (ARTL) Free Cash Flow Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -1.95% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -20.15% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 21.16% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 45.09% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 80.69% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -23.92% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 8.92% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -4.45% |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - | -8.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.28% |
| Sep 30, 2025 | -27.29% |
| Jun 30, 2025 | 36.06% |
| Mar 31, 2025 | 8.03% |
| Nov 30, 2021 | -68.70% |
| Feb 28, 2021 | -47.46% |
| Nov 30, 2020 | -97.73% |
| Aug 31, 2020 | -76.76% |
| May 31, 2020 | -203.05% |
| Feb 29, 2020 | -423.30% |
| Nov 30, 2019 | -339.28% |
| May 31, 2019 | -434.97% |
| Feb 28, 2019 | -1,148.22% |
| Nov 30, 2018 | -204.15% |
| Aug 31, 2018 | -464.79% |
| May 31, 2018 | -385.86% |
| Feb 28, 2018 | -323.62% |
| Nov 30, 2017 | -598.99% |
| Aug 31, 2017 | -570.51% |
| May 31, 2017 | -35.78% |